GlassScriptPhysician profile
Katherin E Leckie
NPI 1033569231
$2,500.80
in general payments reported to CMS, 2019-2025
10 companies · $311 in 2025
The $311 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $314 · 2023: $635 · 2024: $1,240 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,837 · Travel and Lodging: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,836.58 |
| Travel and Lodging | $350.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $829.12 | 2023-2024 | Turbohawk |
| W. L. Gore & Associates, INC. | $327.24 | 2024-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Penumbra, INC. | $324.57 | 2024 | Penumbra System, Indigo System |
| Silk Road Medical, INC. | $305.35 | 2022-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Abbott Laboratories | $203.02 | 2022-2025 | Esprit |
| Philips North America LLC | $179.08 | 2023 | (6577) Visions 014 |
| Boston Scientific Corporation | $132.31 | 2025 | Eluvia |
| Shockwave Medical, INC | $108.32 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $75.60 | 2023 | Xarelto |
| Stryker Corporation | $16.19 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherin Leckie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.